Department of Gastroenterology and Hepatology, Tokyo Medical and Dental University, 1-5-45, Yushima, Bunkyo-ku, Tokyo, 113-8519, Japan.
J Crohns Colitis. 2011 Aug;5(4):317-23. doi: 10.1016/j.crohns.2011.02.003. Epub 2011 Mar 11.
Neither conceptions and pregnancy outcomes nor the safety of medications for childbearing inflammatory bowel disease (IBD) patients has been investigated in Asia. The aim of this study is to analyse conception and pregnancy outcomes of Japanese female IBD patients.
We conducted a retrospective cohort study of pregnant IBD patients at 6 institutions. The incidences of abortion, Caesarean delivery, low birth weight (LBW) (<2500g), and congenital malformation were analysed in these patients. Risk factors associated with adverse outcomes in IBD patients were also assessed.
A total of 325 patients experienced 534 conceptions. Among these, 303 conceptions (57%) were observed during/after disease onset. Although conceptions and pregnancy outcomes after disease onset were comparable to the observed levels prior to disease onset in UC patients, the incidences of spontaneous abortion (OR 5.3; 95%CI 1.1-25.0) and Caesarean delivery (OR 4.8; 95%CI 1.5-15.0) were significantly higher in Crohn's disease (CD) patients whose conceptions occurred after disease onset compared to CD patients whose conceptions occurred before disease onset. The incidences of spontaneous abortion, LBW, and Caesarean delivery were higher in CD patients who had a history of surgery for perianal lesions than in those who did not have perianal lesions or who had ulcerative colitis (UC). In the IBD patients studied after disease onset, independent risk factors for spontaneous abortions included a history of previous treatment for sterility (OR 2.9; 95%CI 1.2-7.0). Independent risk factors for Caesarean operation (OR 4.1, 95% CI: 1.7-10.1) and LBW (OR 3.5, 95% CI: 1.3-9.1) included a history of bowel resection for the treatment of IBD. Congenital malformation was not associated with the factors of type of disease, smoking, and previous surgery.
In Japanese UC patients, conception and pregnancy outcomes after disease onset were comparable to the outcomes observed prior to disease onset, whereas CD appeared to be associated with adverse outcomes. Caesarean operation and LBW were more frequently observed in CD patients who had a history of surgery for perianal lesions and bowel resection.
在亚洲,人们尚未对生育期炎症性肠病(IBD)患者的妊娠结局和药物安全性进行研究。本研究旨在分析日本女性 IBD 患者的妊娠结局。
我们对 6 家机构的妊娠 IBD 患者进行了回顾性队列研究。分析了这些患者的流产、剖宫产、低出生体重(LBW)(<2500g)和先天性畸形的发生率。还评估了与 IBD 患者不良结局相关的风险因素。
共有 325 名患者经历了 534 次妊娠。其中,303 次妊娠(57%)发生在疾病发作后。尽管 UC 患者的疾病发作后妊娠结局与疾病发作前的观察水平相当,但疾病发作后妊娠的克罗恩病(CD)患者的自发性流产(OR 5.3;95%CI 1.1-25.0)和剖宫产(OR 4.8;95%CI 1.5-15.0)发生率明显高于疾病发作前妊娠的 CD 患者。与无肛周病变或溃疡性结肠炎(UC)的患者相比,有肛周病变手术史的 CD 患者的自发性流产、LBW 和剖宫产发生率更高。在研究中,与疾病发作后 IBD 患者的自发性流产独立相关的风险因素包括既往治疗不孕症的病史(OR 2.9;95%CI 1.2-7.0)。剖宫产手术(OR 4.1,95%CI:1.7-10.1)和 LBW(OR 3.5,95%CI:1.3-9.1)的独立风险因素包括治疗 IBD 的肠切除术史。先天性畸形与疾病类型、吸烟和既往手术无关。
在日本 UC 患者中,疾病发作后妊娠结局与疾病发作前观察到的结局相当,而 CD 似乎与不良结局相关。有肛周病变手术史和肠切除术史的 CD 患者更常发生剖宫产和 LBW。